Patient Participation

Michele Russell-Einhorn, Chief Compliance Officer at Advarra discusses safety, speed, and ethics in COVID-19 vaccine trials.

Building authentic trust lays at the heart of creating more patient-centric trials.

Understanding the role of social determinants on clinical trial participation and trust.

Co-conveners of the newly formed Decentralized Trials & Research Alliance, Amir Kalali, MD and Craig Lipset discuss the alliance as well as how COVID-19 has impacted the industry.

Hybrid studies, patient-centric tools, and collaborations create big changes for clinical trials and stakeholders during COVID-19.

EVP and General Manager of Hū, April Lewis, discusses why the industry has seen a decline in trial participation and what Hū is doing to combat it.

Eliminating barriers to engage underrepresented populations.

Randomized controlled trials establish strict inclusion and exclusion criteria in an effort to optimize the cohort of trial participants.

Recognizing pre-pandemic pain points, such as patient engagement and protocol development, could lead to post-pandemic trial success.

Evaluating the lessons learned about trial sites from COVID-19 to form new strategies and improve patient safety for the future.

With the assistance of mobile research nursing, in-home visits provide solid alternative to trial participants, especially during COVID-19.

Jody Casey of Elligo Health Research gives insight into the issue of diversity in trials and what needs to be done to correct it.

Practical suggestions for identifying what actionable insights have been impactful on clinical studies.

The pandemic has thus far disproportionally impacted minority populations, and our ongoing failure to adequately represent all patients regardless of demographic background has never been more important to remedy than it is today, writes ACRP Workforce Innovation Officer Beth Harper.

Beyond technology, awareness, and access—cultural competence is key.

Past decades have shown gender-based differences in clinical trial results are often overlooked when considering safety and effectiveness.

If you are an organization content with patient-centric approaches, you are behind. Today it is about patient-driven drug development.

This article highlights how C2N Diagnostics and Firma Clinical Research teamed up to create a successful Alzheimer's diagnostic clinical trial while allowing participants to remain in their homes.

How integrated data platforms can help find the best-suited patients for cancer studies and reduce the burden on care teams.

Case study focused on quest for potential Parkinson’s biomarker highlights opportunities and challenges in site selection.

Recruitment study tests the use of a ride-sharing service.

Exploring the Institute for Neurodegenerative Disorders’ non-traditional approach to engaging community physicians.

President of Commercial Solutions at Syneos Health, Michelle Keefe, writes how the industry must take an additional step beyond explaining and predicting customer behavior, and employ evidence-based strategies to change their behavior by helping customers make well-informed decisions.

A case study of a Parkinson’s disease trial demonstrates how one study team met its enrollment goals.

Tracking the evolution and effectiveness of CISCRP’s clinical research awareness and literacy campaigns.

First column in this series looks at the effectiveness of digital marketing as an outreach tool.

How mapping patients’ health journeys can drive a deeper understanding of their experiences and motivations.

One nonprofit’s efforts to raise the relevance of the clinical research enterprise.

Age diversity in clinical trials benefits both the patient experience and the success of the trial.

Providing easy to understand and culturally appropriate investigational medication education and support can make all the difference in improving the patient experience.